Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
14,002,438
-
Total 13F shares
-
2,537,025
-
Share change
-
+2,162,467
-
Total reported value
-
$1,877,635
-
Price per share
-
$0.74
-
Number of holders
-
18
-
Value change
-
+$1,555,416
-
Number of buys
-
15
-
Number of sells
-
4
Institutional Holders of MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX) as of Q4 2025
As of 31 Dec 2025,
MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,537,025 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, UBS Group AG, BOOTHBAY FUND MANAGEMENT, LLC, NORTHERN TRUST CORP, Ackerman Capital Advisors, LLC, and Virtu Financial LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.